Is A Bounce Coming? Seelos Therapeutics Inc (NASDAQ:SEEL) Falls After The Update

Seelos Therapeutics Inc (NASDAQ: SEEL) stock is trading slightly lower in the opening session on Wednesday. The stock has seen a nice jump so far this year with a gain of 130%.

Market Action

As of 11:22, SEEL stock slid by 2% at $3.28. The stock has traded 2.25 million shares, compared to its average volume of 10.63 million shares.  The stock opened at $3.46 and moved in a range of $3.2500 – 3.5000.

Seelos Therapeutics Announces its Inclusion in the First U.S. Listed Exchange Traded Fund (ETF) Focused on Psychedelics

  • announced that it has been included in the Defiance Next Gen Altered Experience ETF, the first U.S. listed Exchange Traded Fund (ETF) focused on psychedelics which began trading on Friday, May 28th on the New York Stock Exchange under the symbol PSY.
  • Seelos’ inclusion is based on its lead program SLS-002 (intranasal racemic ketamine), which recently released positive top-line data from Part 1, the open-label cohort, of its potentially registrational Proof-of-Concept study for Acute Suicidal Ideation and Behavior (ASIB) in patients with Major Depressive Disorder (MDD).
  • The Defiance Next Gen Altered Experience ETF, managed by Defiance ETFs, LLC, is the first U.S. listed psychedelic ETF which seeks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index, a rules-based index that tracks the performance of companies, listed in North American Exchanges, that operate business models focused on the usage of Psychedelics, Medical Cannabis, and Ketamine for medicinal and health treatment purposes. Companies included in the ETF must have a minimum market capitalization of $75 million, and operate in the production of, distribution of, or services related to medical psychedelics, medical cannabis or ketamine and its derivatives.

Related Posts

About The Author